SBIR/STTR Research Award
DEVELOPMENT OF RABBIT MONOCLONAL ANTIBODIES FOR FERRET BIOMARKERS
Award amount
$356,021Program and phase
SBIR · Phase IAward year
2021Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- AVANTGEN INC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- WLNHKNPNT2M7
- Solicitation number
- PHS2021-1
- Topic code
- 94
Research abstract
This project is to generate and characterize rabbit monoclonal antibodies (mAbs) against five ferret biomarkers, focusing on inflammatory cytokines produced following immune activation in ferrets. Generated mAbs will undergo extensive immunological characterization. The successful completion of this project will address an urgent need for specific and sensitive reagents capable of measuring cytokine responses in the ferret model for infectious disease and immunology research.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- DEVELOPMENT OF RABBIT MONOCLONAL ANTIBODIES FOR FERRET BIOMARKERS.
- DEVELOPMENT OF RABBIT MONOCLONAL ANTIBODIES FOR INDIAN FLYING FOX (BAT) BIOMARKERS
- A novel approach for treating myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML)
- DEVELOPMENT OF RAPID AND POINT-OF-CARE DIAGNOSTIC KIT FOR HEPATITIS C VIRUS DETECTION
- TOPIC 372:DEVELOPMENT AND VALIDATION OF NON-MOUSE REAGENTS TO ENABLE PRECLINICAL DEVELOPMENT OF NOVEL THERAPEUTICS
Research funding history
24 SBIR/STTR records share this UEI (2008–2025). Reported award amounts total $14,979,724. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services